SPY366.63+4.57 1.26%
DIA299.10+2.48 0.84%
IXIC12,367.34+168.60 1.38%

Fennec Pharmaceuticals Q3 EPS $(0.24) Down From $(0.09) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.24) per share. This is a 166.67 percent decrease over losses of $(0.09) per share from the same period last year.

· 11/16/2020 07:18
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.24) per share. This is a 166.67 percent decrease over losses of $(0.09) per share from the same period last year.